Bar Harbor Wealth Management Sells 698 Shares of Danaher Co. (NYSE:DHR)

Bar Harbor Wealth Management trimmed its position in Danaher Co. (NYSE:DHR) by 2.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 29,281 shares of the conglomerate’s stock after selling 698 shares during the quarter. Bar Harbor Wealth Management’s holdings in Danaher were worth $6,721,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Marshall & Sullivan Inc. WA boosted its stake in shares of Danaher by 1.6% during the 4th quarter. Marshall & Sullivan Inc. WA now owns 23,226 shares of the conglomerate’s stock worth $5,332,000 after acquiring an additional 356 shares during the period. Sivia Capital Partners LLC lifted its holdings in Danaher by 5.7% during the 4th quarter. Sivia Capital Partners LLC now owns 1,410 shares of the conglomerate’s stock valued at $324,000 after purchasing an additional 76 shares during the last quarter. Clean Yield Group boosted its position in Danaher by 26.8% during the fourth quarter. Clean Yield Group now owns 932 shares of the conglomerate’s stock worth $214,000 after purchasing an additional 197 shares during the period. Wedmont Private Capital raised its position in shares of Danaher by 4.2% in the fourth quarter. Wedmont Private Capital now owns 5,618 shares of the conglomerate’s stock valued at $1,321,000 after purchasing an additional 229 shares during the period. Finally, Agate Pass Investment Management LLC lifted its stake in shares of Danaher by 1.3% during the 4th quarter. Agate Pass Investment Management LLC now owns 13,580 shares of the conglomerate’s stock worth $3,117,000 after buying an additional 178 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Up 2.0 %

Shares of NYSE:DHR traded up $4.76 during mid-day trading on Monday, reaching $239.83. 2,611,176 shares of the company’s stock were exchanged, compared to its average volume of 2,785,549. The firm has a market capitalization of $173.22 billion, a price-to-earnings ratio of 45.77, a PEG ratio of 4.32 and a beta of 0.83. Danaher Co. has a twelve month low of $222.53 and a twelve month high of $281.70. The business’s fifty day moving average price is $235.67 and its 200-day moving average price is $253.73. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the prior year, the firm posted $2.02 earnings per share. The business’s quarterly revenue was up 3.1% on a year-over-year basis. On average, research analysts predict that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Analyst Upgrades and Downgrades

DHR has been the topic of several research analyst reports. TD Cowen increased their price target on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. UBS Group dropped their target price on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a research report on Friday, December 13th. Finally, Royal Bank of Canada cut their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $286.80.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.